The World Anti-Doping Agency (WADA) wishes to remind potential candidates that the deadline to apply for vacant positions on ...
This Checklist is to guide the athlete and their physician on the requirements for a TUE application, related to Intravenous Infusions, that will allow the TUE Committee to assess whether the relevant ...
Clostebol (4-chloro-testosterone; 4-chloro-4-androsten-17-ol-3-one) is an anabolic androgenic steroid (AAS) derivative from testosterone. In humans, among the legitimate therapeutic indications of ...
It is well known that the use performance-enhancing substances by athletes provide an unfair advantage and doping is contrary to the ‘the spirit of sport’. However, a randomised response surveys ...
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analogue, used for the reduction of excess abdominal fat in HIV-infected adults. As a GHRH analogue, it triggers the secretion of ...
Our main purpose of this study is to evaluate non-analytical factors that may influence the markers in the serum steroid profiles and endocrine profiles, which are indirect methods to detect doping ...
The World Anti-Doping Agency (WADA) responds to a Reuters story of 7 August 2024 exposing a scheme whereby the U.S. Anti-Doping Agency (USADA) allowed athletes who had doped, to compete for years, in ...
The World Anti-Doping Agency (WADA) wishes to remind the global anti-doping community that experts interested in joining the Agency’s Expert Advisory Groups (EAGs) may submit applications to the ...
The World Anti-Doping Agency (WADA) invites stakeholders to the following webinar in September regarding the ongoing 2027 World Anti-Doping Code (Code) Update Process. Please note that the webinar is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback